Jump Financial LLC Invests $1.73 Million in Omnicell, Inc. (NASDAQ:OMCL)

Jump Financial LLC purchased a new stake in Omnicell, Inc. (NASDAQ:OMCL) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 38,928 shares of the company’s stock, valued at approximately $1,733,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of OMCL. Geode Capital Management LLC increased its position in shares of Omnicell by 0.3% during the third quarter. Geode Capital Management LLC now owns 1,104,745 shares of the company’s stock worth $48,176,000 after acquiring an additional 2,877 shares in the last quarter. Shaker Investments LLC OH bought a new stake in Omnicell during the 4th quarter worth approximately $550,000. Empowered Funds LLC purchased a new stake in shares of Omnicell in the fourth quarter worth approximately $388,000. Exchange Traded Concepts LLC lifted its holdings in shares of Omnicell by 6.7% in the fourth quarter. Exchange Traded Concepts LLC now owns 319,682 shares of the company’s stock valued at $14,232,000 after purchasing an additional 20,031 shares in the last quarter. Finally, SG Americas Securities LLC boosted its position in shares of Omnicell by 56.5% during the fourth quarter. SG Americas Securities LLC now owns 39,359 shares of the company’s stock valued at $1,752,000 after buying an additional 14,202 shares during the last quarter. Institutional investors own 97.70% of the company’s stock.

Omnicell Price Performance

Shares of NASDAQ OMCL opened at $30.28 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.22 and a debt-to-equity ratio of 0.13. The stock has a fifty day simple moving average of $35.27 and a two-hundred day simple moving average of $41.27. Omnicell, Inc. has a 1-year low of $25.12 and a 1-year high of $55.75. The firm has a market cap of $1.42 billion, a price-to-earnings ratio of 112.15, a price-to-earnings-growth ratio of 7.53 and a beta of 0.78.

Omnicell (NASDAQ:OMCL) last announced its quarterly earnings data on Thursday, February 6th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.12). Omnicell had a return on equity of 3.82% and a net margin of 1.13%. Analysts anticipate that Omnicell, Inc. will post 1.09 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have weighed in on OMCL. JPMorgan Chase & Co. dropped their price objective on Omnicell from $44.00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday, March 20th. StockNews.com upgraded shares of Omnicell from a “hold” rating to a “buy” rating in a report on Tuesday, April 15th. Bank of America decreased their price objective on shares of Omnicell from $54.00 to $46.00 and set a “neutral” rating for the company in a research note on Monday, January 6th. Benchmark reaffirmed a “buy” rating and issued a $62.00 target price on shares of Omnicell in a report on Tuesday, February 4th. Finally, Wells Fargo & Company dropped their price target on Omnicell from $40.00 to $38.00 and set an “equal weight” rating on the stock in a report on Thursday. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, Omnicell currently has a consensus rating of “Hold” and an average price target of $50.67.

Omnicell Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.